Juilee Rege1, Aya T Nanba2, Richard J Auchus2,3, Jianwei Ren2, Hwei-Ming Peng2, William E Rainey1,2, Adina F Turcu2. 1. Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan. 2. Division of Metabolism, Endocrinology, and Diabetes, University of Michigan, Ann Arbor, Michigan. 3. Department of Pharmacology, University of Michigan, Ann Arbor, Michigan.
Abstract
Background: Dehydroepiandrosterone sulfate (DHEAS) is the most abundant steroid in human circulation, and adrenocorticotropic hormone (ACTH) is considered the major regulator of its synthesis. Pregnenolone sulfate (PregS) and 5-androstenediol-3-sulfate (AdiolS) have recently emerged as biomarkers of adrenal disorders. Objective: To define the relative human adrenal production of Δ5-steroid sulfates under basal and cosyntropin-stimulated conditions. Methods: Liquid chromatography-tandem mass spectrometry was used to quantify three unconjugated and four sulfated Δ5-steroids in (1) paired adrenal vein (AV) and mixed venous serum samples (21 patients) and (2) cultured human adrenal cells both before and after cosyntropin stimulation, (3) microdissected zona fasciculata (ZF) and zona reticularis (ZR) from five human adrenal glands, and (4) a reconstituted in vitro human 17α-hydroxylase/17,20-lyase/(P450 17A1) system. Results: Of the steroid sulfates, PregS had the greatest increase after cosyntropin stimulation in the AV (32-fold), whereas DHEAS responded modestly (1.8-fold). PregS attained concentrations comparable to those of DHEAS in the AV after cosyntropin stimulation (AV DHEAS/PregS, 24 and 1.3 before and after cosyntropin, respectively). In cultured adrenal cells, PregS demonstrated the sharpest response to cosyntropin, whereas DHEAS responded only modestly (21-fold vs 1.8-fold higher compared with unstimulated cells at 3 hours, respectively). Steroid analyses in isolated ZF and ZR showed similar amounts of PregS and 17α-hydroxypregnenolone in both zones, whereas DHEAS and AdiolS were higher in ZR (P < 0.05). Conclusion: Our studies demonstrated that unlike DHEAS, PregS displayed a prominent acute response to cosyntropin. PregS could be used to interrogate the acute adrenal response to ACTH stimulation and as a biomarker in various adrenal disorders.
Background: Dehydroepiandrosterone sulfate (DHEAS) is the most abundant steroid in human circulation, and adrenocorticotropic hormone (ACTH) is considered the major regulator of its synthesis. Pregnenolone sulfate (PregS) and 5-androstenediol-3-sulfate (AdiolS) have recently emerged as biomarkers of adrenal disorders. Objective: To define the relative human adrenal production of Δ5-steroid sulfates under basal and cosyntropin-stimulated conditions. Methods: Liquid chromatography-tandem mass spectrometry was used to quantify three unconjugated and four sulfated Δ5-steroids in (1) paired adrenal vein (AV) and mixed venous serum samples (21 patients) and (2) cultured human adrenal cells both before and after cosyntropin stimulation, (3) microdissected zona fasciculata (ZF) and zona reticularis (ZR) from five human adrenal glands, and (4) a reconstituted in vitro human 17α-hydroxylase/17,20-lyase/(P450 17A1) system. Results: Of the steroid sulfates, PregS had the greatest increase after cosyntropin stimulation in the AV (32-fold), whereas DHEAS responded modestly (1.8-fold). PregS attained concentrations comparable to those of DHEAS in the AV after cosyntropin stimulation (AV DHEAS/PregS, 24 and 1.3 before and after cosyntropin, respectively). In cultured adrenal cells, PregS demonstrated the sharpest response to cosyntropin, whereas DHEAS responded only modestly (21-fold vs 1.8-fold higher compared with unstimulated cells at 3 hours, respectively). Steroid analyses in isolated ZF and ZR showed similar amounts of PregS and 17α-hydroxypregnenolone in both zones, whereas DHEAS and AdiolS were higher in ZR (P < 0.05). Conclusion: Our studies demonstrated that unlike DHEAS, PregS displayed a prominent acute response to cosyntropin. PregS could be used to interrogate the acute adrenal response to ACTH stimulation and as a biomarker in various adrenal disorders.
Authors: Graeme Eisenhofer; Tanja Dekkers; Mirko Peitzsch; Anna S Dietz; Martin Bidlingmaier; Marcus Treitl; Tracy A Williams; Stefan R Bornstein; Matthias Haase; L C Rump; Holger S Willenberg; Felix Beuschlein; Jaap Deinum; Jacques W M Lenders; Martin Reincke Journal: Clin Chem Date: 2016-01-19 Impact factor: 8.327
Authors: A K Munabi; P Feuillan; R C Staton; D Rodbard; G P Chrousos; R E Anderson; M D Strober; D L Loriaux; G B Cutler Journal: J Clin Endocrinol Metab Date: 1986-10 Impact factor: 5.958
Authors: M Conall Dennedy; Anand K Annamalai; Olivia Prankerd-Smith; Natalie Freeman; Kuhan Vengopal; Johann Graggaber; Olympia Koulouri; Andrew S Powlson; Ashley Shaw; David J Halsall; Mark Gurnell Journal: J Clin Endocrinol Metab Date: 2017-03-01 Impact factor: 5.958
Authors: Francis K Yoshimoto; Hwei-Ming Peng; Haoming Zhang; Sean M Anderson; Richard J Auchus Journal: Biochemistry Date: 2014-11-25 Impact factor: 3.162
Authors: Lina Schiffer; Lise Barnard; Elizabeth S Baranowski; Lorna C Gilligan; Angela E Taylor; Wiebke Arlt; Cedric H L Shackleton; Karl-Heinz Storbeck Journal: J Steroid Biochem Mol Biol Date: 2019-07-27 Impact factor: 4.292
Authors: Aya T Nanba; Juilee Rege; Jianwei Ren; Richard J Auchus; William E Rainey; Adina F Turcu Journal: J Clin Endocrinol Metab Date: 2019-07-01 Impact factor: 5.958
Authors: Juilee Rege; Scott Garber; Alan J Conley; Ruth M Elsey; Adina F Turcu; Richard J Auchus; William E Rainey Journal: J Steroid Biochem Mol Biol Date: 2019-04-05 Impact factor: 4.292
Authors: Adina F Turcu; Ashwini Mallappa; Aikaterini A Nella; Xuan Chen; Lili Zhao; Aya T Nanba; James Brian Byrd; Richard J Auchus; Deborah P Merke Journal: Front Endocrinol (Lausanne) Date: 2021-11-16 Impact factor: 5.555